Tecan Group AG (OTCPK:TCHBF)
$ 277 0 (0%) Market Cap: 3.19 Bil Enterprise Value: 3.19 Bil PE Ratio: 27.91 PB Ratio: 2.00 GF Score: 87/100

Tecan Group AG at UBS Global Healthcare Conference Transcript

May 23, 2022 / 12:30PM GMT
Release Date Price: $315
Carlos Vasques

All right. Good morning, everyone in the audience and those streaming. Welcome to the 2022 UBS Global Healthcare Conference. I hope you were all able to grab some breakfast and have been enjoying the speakers thus far. My name is Carlos Vasques, and I'm an Associate Director here on the Health Care team, and thank you for joining us. It's bright, early on a Monday, but we're excited to be speaking with Tecan Group Global Laboratory and Life Science Equipment Company. To walk us through the story today, we're pleased to have Dr. Achim von Leoprechting Chief Executive Officer at Tecan Group. Dr. Achim has spent nearly a decade with the company, having led as its CEO since 2019.

This is meant to be an interactive session. So if you have questions, feel free to submit them by scanning the QR codes provided. As a reminder, right after Dr. Achim through his presentation, we can dive into those.

So Dr. Achim, thank you so much for joining us. The floor is yours.

Achim von Leoprechting
Tecan Group AG - CEO & Member of Management Board

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot